PRISMA Maternal and Newborn Health Study
Launched by GEORGE WASHINGTON UNIVERSITY · Jun 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PRISMA Maternal and Newborn Health Study is a clinical trial that aims to improve the health and well-being of pregnant women and their newborns. The study focuses on understanding the risk factors that can lead to serious health issues during pregnancy, such as stillbirth or maternal complications. By gathering detailed information about these risks, the researchers hope to develop better strategies and services to ensure healthier pregnancies and births, especially in areas where healthcare services may not be as strong.
To participate in the trial, women must live in specific countries and meet certain age requirements (15 years or older in Ghana, Pakistan, and Zambia, and 18 years or older in Kenya and India). They should be pregnant and less than 20 weeks along, confirmed by an ultrasound. Participants can expect to contribute to valuable research that could lead to improved maternity care, and they will be asked to provide informed consent before joining. This study is particularly important as it seeks to fill gaps in current knowledge about pregnancy care in low- and middle-income countries.
Gender
FEMALE
Eligibility criteria
- A woman who meets the following inclusion criteria during screening may be enrolled:
- • Lives within the study catchment area;
- * Meets minimum age requirement in study site country:
- • Ghana: 15 years of age;
- • Kenya: 18 years of age or those who meet the criteria of emancipated minors;
- • Pakistan: 15 years of age or those who meet the criteria of emancipated minors;
- • Zambia: 15 years of age;
- • India: 18 years of age
- • Intrauterine pregnancy \<20 weeks gestation verified via ultrasound;
- • Provides informed consent.
- A woman who meets the following exclusion criteria during screening may NOT be enrolled:
- • Nonviable (e.g. ectopic or molar) pregnancy;
- • Plans to relocate outside of the study catchment area during pregnancy and/or postpartum.
About George Washington University
George Washington University (GWU) is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, GWU leverages its extensive resources and expertise to facilitate innovative studies that aim to improve healthcare outcomes. The university's commitment to ethical research practices, collaboration with multidisciplinary teams, and engagement with diverse populations underscores its role in addressing critical health challenges. By fostering a rigorous scientific environment, GWU strives to translate research findings into effective clinical applications, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, , Pakistan
Kintampo, , Ghana
Kisumu, , Kenya
Vellore, , India
Lusaka, , Zambia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported